benzoic acid;N-[(4-cyanophenyl)methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;methanamine;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide

C105H142N12O7 — CID 172967396

IUPACbenzoic acid;N-[(4-cyanophenyl)methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;methanamine;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide
SMILESCCCCCc1ccc(C(=O)N(Cc2ccc(-c3noc(-c4ccccc4)n3)cc2)C2CCN(CCC(C)C)CC2)cc1.CCCCCc1ccc(C(=O)N(Cc2ccc(/C(N)=N/O)cc2)C2CCN(CCC(C)C)CC2)cc1.CCCCCc1ccc(C(=O)N(Cc2ccc(C#N)cc2)C2CCN(CCC(C)C)CC2)cc1.CN.O=C(O)c1ccccc1
InChIInChI=1S/C37H46N4O2.C30H44N4O2.C30H41N3O.C7H6O2.CH5N/c1-4-5-7-10-29-13-19-33(20-14-29)37(42)41(34-22-25-40(26-23-34)24-21-28(2)3)27-30-15-17-31(18-16-30)35-38-36(43-39-35)32-11-8-6-9-12-32;1-4-5-6-7-24-8-14-27(15-9-24)30(35)34(22-25-10-12-26(13-11-25)29(31)32-36)28-17-20-33(21-18-28)19-16-23(2)3;1-4-5-6-7-25-12-14-28(15-13-25)30(34)33(23-27-10-8-26(22-31)9-11-27)29-17-20-32(21-18-29)19-16-24(2)3;8-7(9)6-4-2-1-3-5-6;1-2/h6,8-9,11-20,28,34H,4-5,7,10,21-27H2,1-3H3;8-15,23,28,36H,4-7,16-22H2,1-3H3,(H2,31,32);8-15,24,29H,4-7,16-21,23H2,1-3H3;1-5H,(H,8,9);2H2,1H3
InChIKeyHFVOYPNKDSYVPO-UHFFFAOYSA-N
MW1684.37 g/mol
LogP21.36
Rot. Bonds37

About benzoic acid;N-[(4-cyanophenyl)methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;methanamine;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide

benzoic acid;N-[(4-cyanophenyl)methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;methanamine;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide (PubChem CID 172967396) has the molecular formula C105H142N12O7 and a molecular weight of 1684.37 g/mol. Its IUPAC name is benzoic acid;N-[(4-cyanophenyl)methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;methanamine;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide.

Molecular Properties

Compound Namebenzoic acid;N-[(4-cyanophenyl)methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;methanamine;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide
PubChem CID172967396
Molecular FormulaC105H142N12O7
Molecular Weight1684.37 g/mol
Exact Mass1683.11
IUPAC Namebenzoic acid;N-[(4-cyanophenyl)methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;methanamine;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide
SMILESCCCCCc1ccc(C(=O)N(Cc2ccc(-c3noc(-c4ccccc4)n3)cc2)C2CCN(CCC(C)C)CC2)cc1.CCCCCc1ccc(C(=O)N(Cc2ccc(/C(N)=N/O)cc2)C2CCN(CCC(C)C)CC2)cc1.CCCCCc1ccc(C(=O)N(Cc2ccc(C#N)cc2)C2CCN(CCC(C)C)CC2)cc1.CN.O=C(O)c1ccccc1
InChIInChI=1S/C37H46N4O2.C30H44N4O2.C30H41N3O.C7H6O2.CH5N/c1-4-5-7-10-29-13-19-33(20-14-29)37(42)41(34-22-25-40(26-23-34)24-21-28(2)3)27-30-15-17-31(18-16-30)35-38-36(43-39-35)32-11-8-6-9-12-32;1-4-5-6-7-24-8-14-27(15-9-24)30(35)34(22-25-10-12-26(13-11-25)29(31)32-36)28-17-20-33(21-18-28)19-16-23(2)3;1-4-5-6-7-25-12-14-28(15-13-25)30(34)33(23-27-10-8-26(22-31)9-11-27)29-17-20-32(21-18-29)19-16-24(2)3;8-7(9)6-4-2-1-3-5-6;1-2/h6,8-9,11-20,28,34H,4-5,7,10,21-27H2,1-3H3;8-15,23,28,36H,4-7,16-22H2,1-3H3,(H2,31,32);8-15,24,29H,4-7,16-21,23H2,1-3H3;1-5H,(H,8,9);2H2,1H3
InChIKeyHFVOYPNKDSYVPO-UHFFFAOYSA-N
XLogP21.36
TPSA255.29 Ų
H-Bond Donors4
H-Bond Acceptors14
Rotatable Bonds37
Heavy Atoms124
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001684.37
LogP ≤ 521.36
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'oxime_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze benzoic acid;N-[(4-cyanophenyl)methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;methanamine;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of benzoic acid;N-[(4-cyanophenyl)methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;methanamine;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide?
The IUPAC name of benzoic acid;N-[(4-cyanophenyl)methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;methanamine;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide (CID 172967396) is benzoic acid;N-[(4-cyanophenyl)methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;methanamine;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide.
What is the SMILES notation for benzoic acid;N-[(4-cyanophenyl)methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;methanamine;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide?
The canonical SMILES for benzoic acid;N-[(4-cyanophenyl)methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;methanamine;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide is CCCCCc1ccc(C(=O)N(Cc2ccc(-c3noc(-c4ccccc4)n3)cc2)C2CCN(CCC(C)C)CC2)cc1.CCCCCc1ccc(C(=O)N(Cc2ccc(/C(N)=N/O)cc2)C2CCN(CCC(C)C)CC2)cc1.CCCCCc1ccc(C(=O)N(Cc2ccc(C#N)cc2)C2CCN(CCC(C)C)CC2)cc1.CN.O=C(O)c1ccccc1.
What is the InChIKey of benzoic acid;N-[(4-cyanophenyl)methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;methanamine;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide?
The InChIKey is HFVOYPNKDSYVPO-UHFFFAOYSA-N. The full InChI is InChI=1S/C37H46N4O2.C30H44N4O2.C30H41N3O.C7H6O2.CH5N/c1-4-5-7-10-29-13-19-33(20-14-29)37(42)41(34-22-25-40(26-23-34)24-21-28(2)3)27-30-15-17-31(18-16-30)35-38-36(43-39-35)32-11-8-6-9-12-32;1-4-5-6-7-24-8-14-27(15-9-24)30(35)34(22-25-10-12-26(13-11-25)29(31)32-36)28-17-20-33(21-18-28)19-16-23(2)3;1-4-5-6-7-25-12-14-28(15-13-25)30(34)33(23-27-10-8-26(22-31)9-11-27)29-17-20-32(21-18-29)19-16-24(2)3;8-7(9)6-4-2-1-3-5-6;1-2/h6,8-9,11-20,28,34H,4-5,7,10,21-27H2,1-3H3;8-15,23,28,36H,4-7,16-22H2,1-3H3,(H2,31,32);8-15,24,29H,4-7,16-21,23H2,1-3H3;1-5H,(H,8,9);2H2,1H3.
What are the key properties of benzoic acid;N-[(4-cyanophenyl)methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;methanamine;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide?
benzoic acid;N-[(4-cyanophenyl)methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;methanamine;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide has a molecular weight of 1684.37 g/mol, XLogP of 21.36, 37 rotatable bonds, 4 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for benzoic acid;N-[(4-cyanophenyl)methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;N-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methyl]-N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentylbenzamide;methanamine;N-[1-(3-methylbutyl)piperidin-4-yl]-4-pentyl-N-[[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]benzamide is sourced from PubChem (CID 172967396), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).